 |
市場調查報告書
商品編碼
1391966
酒糟治療市場：按藥物類別、按給藥途徑、按類型、按配銷通路、按地區Rosacea Treatment Market, By Drug Class, By Route of Administration, By Type, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
全球酒糟治療市場規模預計將從 2023 年的 19.1 億美元增加到 2030 年的 29.6 億美元，預測期內年複合成長率為 6.5%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2022年 | 2023年市場規模 | 19.1億美元 |
| 實績資料 | 2018-2021 | 預測期 | 2023-2030 |
| 預測期年複合成長率 | 6.50% | 2030年市場規模預測 | 29.6億美元 |
圖 1. 2023 年按地區分類的酒糟治療全球市場佔有率(%)
酒糟是一種慢性皮膚病，其特徵是臉部發紅、潮紅和有時含有膿液的小腫塊。儘管這是一種令人沮喪的情況，但有多種治療方案可供選擇。為了治療酒糟症狀並改善患者的生活品質，市場提供了多種治療選擇，包括外用和內服藥物藥物、雷射治療、光療和皮膚護理產品。酒糟的實際病因尚不清楚，但可能涉及許多因素，包括遺傳、環境觸發因素和一些藥物。
市場動態：
在預測期內，認知和診斷的提高也可能推動全球酒糟治療市場的成長。患者和醫療保健專業人員對酒糟的了解越來越多。酒糟盛行率的上升也可能在預測期內繼續推動全球酒糟治療市場的成長。酒糟是一種廣泛存在的慢性皮膚病，影響全世界數百萬人。在預測期內，創新治療方法的創造可能為全球酒糟治療市場創造新的機會。始終需要創造新的、更好的酒糟治療方法。
現有治療方法的療效有限預計將阻礙預測期內全球酒糟治療市場的成長。儘管酒糟治療有多種選擇，但並非所有患者都能獲得積極的結果。
本研究的主要特點
- 本報告對全球酒糟治療市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率。
- 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
- 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
- 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球酒糟治療市場的主要企業。
- 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
- 全球酒糟治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
- 透過用於分析全球酒糟治療市場的各種策略矩陣，將促進相關人員的決策。
目錄
第1章 研究目的與假設
- 研究目標
- 假設
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規及趨勢分析
- 市場動態
- 酒糟盛行率上升
- 現有治療方法的效果有限
- 創造創新治療方法
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 管道分析
- 波特的分析
- 併購場景
第4章酒糟治療市場－冠狀病毒（COVID-19）大流行的影響
- 新型冠狀病毒感染疾病（COVID-19）的流行病學
- 供需面分析
- 經濟影響
第 5 章酒糟治療市場，依藥物類別，2018-2030
- 介紹
- 抗生素
- α促效劑
- 類視色素A
- 皮質類固醇
- 免疫抑制劑
- 其他藥物類別
第6章酒糟治療市場，依給藥途徑，2018-2030
- 介紹
- 局部的
- 口服
第 7 章酒糟治療市場，按類型，2018-2030
- 介紹
- 酒糟
- 酒糟
- 眼部酒糟
- 酒糟
第 8 章酒糟治療市場，依配銷通路，2018-2030
- 介紹
- 醫院藥房
- 零售藥房
- 線上藥房
第9章酒糟治療市場，依地區，2018-2030
- 介紹
- 北美洲
- 美國
- 加拿大
- 雨美國
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- 東南亞國協
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中部非洲
- 南非
第10章競爭形勢
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
第11章 章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI5954
The Global Rosacea Treatment Market size is expected to reach US$ 2.96 billion by 2030, from US$ 1.91 billion in 2023, at a CAGR of 6.5% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1.91 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 6.50% | 2030 Value Projection: | US$ 2.96 Bn |
Figure 1. Global Rosacea Treatment Market Share (%), by Region, 2023
Rosacea is a chronic skin condition characterized by redness, flushing, and sometimes small, pus-filled bumps on the face. It can be a frustrating condition to manage but there are various treatment options available. In order to cure the symptoms of rosacea and enhance patients' quality of life, the market offers a variety of treatment choices, including topical drugs, oral medications, laser therapies, light-based treatments, and skin care products, among others. The actual etiology of rosacea is unknown, but a number of factors, including genetics, environmental triggers, and some drugs, are likely to be involved.
Market Dynamics:
Increasing recognition and diagnosis will continue to fuel the growth of the global rosacea treatment market over the forecast period. Both patients and medical professionals now have a better grasp of rosacea. Rising rosacea prevalence will also continue to fuel the growth of the global rosacea treatment market over the forecast period. A widespread chronic skin disorder that affects millions of individuals worldwide is rosacea. The creation of innovative therapies will create new opportunities for the global rosacea treatment market over the forecast period. The creation of brand-new, better treatments for rosacea is constantly needed.
Limited efficacy of available treatments is expected to hamper the growth of the global rosacea treatment market over the forecast period. Despite the fact that there are numerous rosacea treatment choices, not all patients have good outcomes.
Key features of the study:
- This report provides an in-depth analysis of the global rosacea treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global rosacea treatment market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Galderma, Allergan, Bayer, Foamix Pharmaceuticals, Mayne Pharma, Leo Pharma, Pfizer, Dermira, Nestle Skin Health, Aclaris Therapeutics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rosacea treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rosacea treatment market
Detailed Segmentation:
- Global Rosacea Treatment Market, By Drug Class:
- Antibiotics
- Alpha agonists
- Retinoids
- Corticosteroids
- Immunosuppressants
- Other drug classes
- Global Rosacea Treatment Market, By Route of Administration:
- Topical
- Oral
- Global Rosacea Treatment Market, By Type:
- Erythematotelangiectatic rosacea
- Papulopustular rosacea
- Ocular rosacea
- Phymatous rosacea
- Global Rosacea Treatment Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail pharmacies
- Online pharmacies
- Global Rosacea Treatment Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profile:
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rosacea Treatment, By Drug Class
- Market Rosacea Treatment, By Route of Administration
- Market Rosacea Treatment, By Type
- Market Rosacea Treatment, By Distribution Channel
- Market Rosacea Treatment, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Rosacea Prevalence
- Limited efficacy of available treatments
- Creation of innovative therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rosacea Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rosacea Treatment Market, By Drug Class, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Alpha agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Immunosuppressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Other drug classes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
6. Rosacea Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
7. Rosacea Treatment Market, By Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Erythematotelangiectatic rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Papulopustular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Ocular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Phymatous rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
8. Rosacea Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
9. Rosacea Treatment Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- U.S.
- Canada
- Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth,By Country, 2018 - 2030, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Galderma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
- Analyst Views
11. Section
- Research Methodology
- About us
